Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2007 2
2008 5
2009 4
2010 6
2011 4
2012 5
2013 4
2014 3
2015 6
2016 10
2017 15
2018 16
2019 14
2020 14
2021 25
2022 21
2023 21
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

163 results

Results by year

Filters applied: . Clear all
Page 1
Ultrasound Blood-Brain Barrier Opening and Aducanumab in Alzheimer's Disease.
Rezai AR, D'Haese PF, Finomore V, Carpenter J, Ranjan M, Wilhelmsen K, Mehta RI, Wang P, Najib U, Vieira Ligo Teixeira C, Arsiwala T, Tarabishy A, Tirumalai P, Claassen DO, Hodder S, Haut MW. Rezai AR, et al. Among authors: claassen do. N Engl J Med. 2024 Jan 4;390(1):55-62. doi: 10.1056/NEJMoa2308719. N Engl J Med. 2024. PMID: 38169490
Multiple System Atrophy.
Claassen DO. Claassen DO. Continuum (Minneap Minn). 2022 Oct 1;28(5):1350-1363. doi: 10.1212/CON.0000000000001154. Continuum (Minneap Minn). 2022. PMID: 36222769 Review.
Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial.
Furr Stimming E, Claassen DO, Kayson E, Goldstein J, Mehanna R, Zhang H, Liang GS, Haubenberger D; Huntington Study Group KINECT-HD Collaborators. Furr Stimming E, et al. Among authors: claassen do. Lancet Neurol. 2023 Jun;22(6):494-504. doi: 10.1016/S1474-4422(23)00127-8. Lancet Neurol. 2023. PMID: 37210099 Clinical Trial.
Neurodegeneration and the Cerebellum.
Samson M, Claassen DO. Samson M, et al. Among authors: claassen do. Neurodegener Dis. 2017;17(4-5):155-165. doi: 10.1159/000460818. Epub 2017 May 3. Neurodegener Dis. 2017. PMID: 28463835 Review.
An MDS Evidence-Based Review on Treatments for Huntington's Disease.
Ferreira JJ, Rodrigues FB, Duarte GS, Mestre TA, Bachoud-Levi AC, Bentivoglio AR, Burgunder JM, Cardoso F, Claassen DO, Landwehrmeyer GB, Kulisevsky J, Nirenberg MJ, Rosser A, Roth J, Seppi K, Slawek J, Furr-Stimming E, Tabrizi SJ, Walker FO, Vandenberghe W, Costa J, Sampaio C. Ferreira JJ, et al. Among authors: claassen do. Mov Disord. 2022 Jan;37(1):25-35. doi: 10.1002/mds.28855. Epub 2021 Nov 29. Mov Disord. 2022. PMID: 34842303 Review.
The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study.
Frank S, Testa C, Edmondson MC, Goldstein J, Kayson E, Leavitt BR, Oakes D, O'Neill C, Vaughan C, Whaley J, Gross N, Gordon MF, Savola JM; Huntington Study Group/ARC-HD Investigators and Coordinators. Frank S, et al. CNS Drugs. 2022 Nov;36(11):1207-1216. doi: 10.1007/s40263-022-00956-8. Epub 2022 Oct 15. CNS Drugs. 2022. PMID: 36242718 Free PMC article. Clinical Trial.
Cerebellar impulsivity-compulsivity assessment scale.
Lin CR, Amokrane N, Chen S, Chen TX, Lai RY, Trinh P, Minyetty MJ, Emmerich H, Pan MK, Claassen DO, Kuo SH. Lin CR, et al. Among authors: claassen do. Ann Clin Transl Neurol. 2023 Jan;10(1):48-57. doi: 10.1002/acn3.51698. Epub 2022 Nov 19. Ann Clin Transl Neurol. 2023. PMID: 36401598 Free PMC article.
CSF microRNA in patients with Huntington disease.
Claassen DO, Torres-Russotto D. Claassen DO, et al. Neurology. 2018 Jan 23;90(4):151-152. doi: 10.1212/WNL.0000000000004871. Epub 2017 Dec 27. Neurology. 2018. PMID: 29282335 No abstract available.
Influences of dopaminergic system dysfunction on late-life depression.
Taylor WD, Zald DH, Felger JC, Christman S, Claassen DO, Horga G, Miller JM, Gifford K, Rogers B, Szymkowicz SM, Rutherford BR. Taylor WD, et al. Among authors: claassen do. Mol Psychiatry. 2022 Jan;27(1):180-191. doi: 10.1038/s41380-021-01265-0. Epub 2021 Aug 17. Mol Psychiatry. 2022. PMID: 34404915 Free PMC article. Review.
Huntington disease exacerbates action impulses.
Shiino S, van Wouwe NC, Wylie SA, Claassen DO, McDonell KE. Shiino S, et al. Among authors: claassen do. Front Psychol. 2023 Jun 16;14:1186465. doi: 10.3389/fpsyg.2023.1186465. eCollection 2023. Front Psychol. 2023. PMID: 37397312 Free PMC article.
163 results